Global Womens HealthCare Market Expected to be More than $17.8 billion, at CAGR of Nearly 13.2% by 2024: MarketsAndMarkets

North America commanded the largest share of the Women’s Health Care Market in 2019.

ID: 1555449
recent pressrelease next pressrelease

(businesspress24) - According to the new market research report "Women''s HealthCare Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) - Global forecast to 2024 ", published by MarketsandMarkets

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136585329

The Women''s Health Care Market growth is largely driven by the growing incidence of chronic health conditions among women, government initiatives to curb population growth, growing demand for contraceptives to prevent unintended pregnancies, and the growing focus on R&D by key players for the development of advanced products. On the other hand, the reluctance to use contraceptives is a major factor limiting the Women''s HealthCare Market growth.

Prolia is the largest and fastest-growing segment of the market.

Based on drug, the market is segmented into EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, FORTEO, Premarin, ACTONEL, and ORTHO-TRI-CY LO (28). Prolia is the largest and fastest-growing segment of the market. Prolia has shown a considerable year-on-year growth primarily due to increasing unit demand. Prolia has witnessed positive market growth owing to the increasing prevalence of postmenopausal osteoporosis in the US.

Browse and in-depth TOC on "Women"
127 - Tables
27 - Figures
146 - Pages

The postmenopausal osteoporosis segment is expected to grow at the highest CAGR during the forecast period.

On the basis of application, the market is segmented into hormonal infertility, postmenopausal osteoporosis, endometriosis, contraceptives, menopause, PCOS, and other applications. The postmenopausal osteoporosis segment is expected to grow at a higher CAGR during the forecast period. The growing prevalence of postmenopausal osteoporosis and a high risk of osteoporosis fractures are the prime factors that contribute towards the large share of this segment. Furthermore, the focus of pharmaceutical players on providing effective drugs for postmenopausal osteoporosis also supports the growth of this segment. The postmenopausal osteoporosis segment also holds the largest share of the market owing to these factors.



Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=136585329

In 2018, North America was the largest and the fastest-growing regional market for womenen, easy access to modern contraception as compared to developing countries, and increased healthcare spending also support the growth of this market.

The prominent players in the global Women& Co. (US), Pfizer Inc. (US), Amgen (US), Agile Therapeutics Inc. (US), Ferring Pharmaceuticals (US), Mylan N.V. (US), Lupin (India), Blairex Laboratories (US), Apothecus Pharmaceutical (US), Eli Lilly And Company (US), Novartis AG (Switzerland), and Johnson & Johnson (US).



More information:
http://https://www.marketsandmarkets.com/Market-Reports/womens-health-care-market-136585329.html



Keywords (optional):

womens-healthcare-market,



Company information / Profile:

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

PressRelease by

Requests:

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com



PressContact / Agency:



published by: gajanan
print pressrelease  send to a friend  

Date: 01/24/2020 - 04:15
Language: English
News-ID 1555449
Character count: 3760
Kontakt-Informationen:
Firma: marketsandmarkets
Ansprechpartner: shelly singh Feedback to businesspress24.com about Pressrelease-id:
Stadt: northbook
Telefon: 18886006441

Meldungsart: Financial
Versandart: send
Freigabedatum: 24.01.2020
Comments:



Number of hits: 968

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 80


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.